@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PXRT8NNW-D
  skos:prefLabel "Oxazoles"@fr, "Oxazoles"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-MH3VGMRZ-M .

jvr:-TJ4SNX1S-2
  skos:prefLabel "Nifuratel"@fr, "Nifuratel"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-MH3VGMRZ-M .

jvr:-GZXH27B4-B
  skos:prefLabel "Anti-infectieux"@fr, "Anti-Infective Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-GZ3792FZ-9
  skos:prefLabel "Cyclosérine"@fr, "Cycloserine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-MH3VGMRZ-M .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HP1Q4D28-L
  skos:prefLabel "Furazolidone"@fr, "Furazolidone"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-MH3VGMRZ-M .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q42VKN3G-X
  skos:prefLabel "Linézolide"@fr, "Linezolid"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-MH3VGMRZ-M .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9LB05R5-D
  skos:prefLabel "Inhibiteurs de la synthèse protéique"@fr, "Protein Synthesis Inhibitors"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-MH3VGMRZ-M
  mesh:allowableQualifier jvr:-W6SQV79N-S, jvr:-R0ZCQ8X6-J, jvr:-TJHVZCRZ-0, jvr:-S0CS1X5R-5, jvr:-FWD2BGQ0-9, jvr:-T9HQD7ST-J, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-NB0XHT3S-N, jvr:-NFTHND7Q-8, jvr:-HQRFT0C6-B, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-XV06LPML-W, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-WK5F724J-1, jvr:-M63HSDM7-1, jvr:-NKM836P1-M, jvr:-CB30NGKB-3, jvr:-BT300B3G-Q ;
  a mesh:Descriptor, skos:Concept ;
  skos:altLabel "497-25-6"@fr, "497-25-6"@en, "Dérivés de l'oxazolidinone"@fr, "Oxazolidinone"@en, "Dérivés d'oxazolidinone"@fr ;
  skos:narrower jvr:-GZ3792FZ-9, jvr:-HP1Q4D28-L, jvr:-TJ4SNX1S-2, jvr:-Q42VKN3G-X ;
  skos:hiddenLabel "1,3-Oxazolidin-2-one"@en, "2-Oxazolidone"@en, "2-oxazolidinone"@en, "1,3-Oxazolidine-2-one"@en, "Oxazolidin-2-one"@en, "Oxazolidin-2-one"@fr ;
  skos:inScheme jvr: ;
  mesh:pharmacologicalAction jvr:-Z9LB05R5-D, jvr:-GZXH27B4-B ;
  skos:broader jvr:-PXRT8NNW-D ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D023303> ;
  dc:created "2000-06-23"^^xsd:date ;
  dc:established "2001-01-01"^^xsd:date ;
  skos:prefLabel "Oxazolidinones"@en, "Oxazolidinones"@fr ;
  dc:modified "2020-05-27"^^xsd:date ;
  skos:definition "Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents."@en .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .